Evidence map›Paper›PMID 40306971›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

First-in-Human Serum Stability Studies of [

Veronika Felber, Nadine Holzleitner, Markus Joksch, Tim Suhrbier, Gunhild von Amsberg, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Thomas Günther, Bernd J Krause

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Evaluation of treatment efficacy of theEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. A true theranostic pair -European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Preclinical Evaluation of aACS pharmacology & translational science · 2026
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Veronika FelberDepartment of Chemistry, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
Nadine HolzleitnerDepartment of Chemistry, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
Markus JokschDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
Tim SuhrbierDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
Gunhild von AmsbergDepartment of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and.
Sarah SchwarzenböckDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
Jens KurthDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
Martin HeuschkelDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
Thomas GüntherMolecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University, Stanford, California tgunther@stanford.edu bernd.krause@med.uni-rostock.de.
Bernd J KrauseDepartment of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany; tgunther@stanford.edu bernd.krause@med.uni-rostock.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of PET/CT with gastrin-releasing peptide receptor (GRPR) ligand [

Indexed as

LutetiumRadioisotopesRadiopharmaceuticalsReceptors, BombesinDrug StabilityHumansMaleMolecular Targeted TherapyPositron Emission Tomography Computed TomographyLutetiumLutetium-177RadioisotopesRadiopharmaceuticalsReceptors, Bombesin177LuAMTGfirst-in-humanGRPRin vivo serum stability

Identifiers

PMID40306971
PMCPMC12175978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.